Taraneh Taghavi1, Christopher A Arger2,3,4, Sarah H Heil2,3,4, Stephen T Higgins2,3,4, Rachel F Tyndale1,5,6. 1. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. 2. Center on Tobacco Regulatory Science, University of Vermont, Burlington, VT, USA. 3. Department of Psychiatry, University of Vermont, Burlington, VT, USA. 4. Department of Psychological Science, University of Vermont, Burlington, VT, USA. 5. Department of Psychiatry, University of Toronto, Toronto, ON, Canada. 6. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Abstract
BACKGROUND AND AIMS: Smokers can regulate their nicotine intake by altering the number of cigarettes smoked per day (CPD) and their smoking intensity. The current study aimed to compare the utility of self-reported CPD, total nicotine equivalents (TNE) and urinary cotinine to estimate nicotine intake during pregnancy. DESIGN: Longitudinal smoking behavior and biomarker data were collected at early pregnancy, late pregnancy and at postpartum as part of a smoking cessation trial to examine voucher-based incentives for decreasing smoking. SETTING: Obstetric practices in Burlington, Vermont, United States. PARTICIPANTS: A subset of participants (n = 47) from the parent trial, recruited between December 2006 and June 2012, who provided a urine sample at each assessment during early pregnancy, late pregnancy and postpartum. MEASUREMENTS: Smoking was assessed using self-reported CPD, TNE, TNE/CPD and urinary cotinine. FINDINGS: Pregnant smokers reported smoking 10.4 CPD at early pregnancy, 7.2 CPD at late pregnancy (a 31% reduction at late pregnancy, P = 0.001) and 8.6 CPD at postpartum (a 19% increase from late pregnancy, P = 0.08). TNE exposure was 41% (P = 0.07) and 48% (P = 0.03) lower at early and late pregnancy, respectively, compared to postpartum. TNE/CPD was on average 167% higher at late pregnancy compared to early pregnancy (P = 0.01) and remained high at postpartum, where it was 111% higher compared to early pregnancy (P = 0.007). Uriniary cotinine underestimated nicotine intake by 55% during early pregnancy and by 65% during late pregnancy compared to postpartum (Pinteraction < 0.001); the underestimation was greater in slower (Pinteraction < 0.001) versus faster (Pinteraction = 0.04) nicotine metabolizers. CONCLUSIONS: Neither cigarettes smoked per day (CPD) nor cotinine provides an accurate estimate of nicotine exposure during pregnancy. CPD underestimates nicotine intake substantially due to under-reporting and/or higher intensity of smoking, while cotinine underestimates nicotine intake markedly due to accelerated nicotine (and cotinine) metabolism during pregnancy.
BACKGROUND AND AIMS: Smokers can regulate their nicotine intake by altering the number of cigarettes smoked per day (CPD) and their smoking intensity. The current study aimed to compare the utility of self-reported CPD, total nicotine equivalents (TNE) and urinary cotinine to estimate nicotine intake during pregnancy. DESIGN: Longitudinal smoking behavior and biomarker data were collected at early pregnancy, late pregnancy and at postpartum as part of a smoking cessation trial to examine voucher-based incentives for decreasing smoking. SETTING: Obstetric practices in Burlington, Vermont, United States. PARTICIPANTS: A subset of participants (n = 47) from the parent trial, recruited between December 2006 and June 2012, who provided a urine sample at each assessment during early pregnancy, late pregnancy and postpartum. MEASUREMENTS: Smoking was assessed using self-reported CPD, TNE, TNE/CPD and urinary cotinine. FINDINGS: Pregnant smokers reported smoking 10.4 CPD at early pregnancy, 7.2 CPD at late pregnancy (a 31% reduction at late pregnancy, P = 0.001) and 8.6 CPD at postpartum (a 19% increase from late pregnancy, P = 0.08). TNE exposure was 41% (P = 0.07) and 48% (P = 0.03) lower at early and late pregnancy, respectively, compared to postpartum. TNE/CPD was on average 167% higher at late pregnancy compared to early pregnancy (P = 0.01) and remained high at postpartum, where it was 111% higher compared to early pregnancy (P = 0.007). Uriniary cotinine underestimated nicotine intake by 55% during early pregnancy and by 65% during late pregnancy compared to postpartum (Pinteraction < 0.001); the underestimation was greater in slower (Pinteraction < 0.001) versus faster (Pinteraction = 0.04) nicotine metabolizers. CONCLUSIONS:Neither cigarettes smoked per day (CPD) nor cotinine provides an accurate estimate of nicotine exposure during pregnancy. CPD underestimates nicotine intake substantially due to under-reporting and/or higher intensity of smoking, while cotinine underestimates nicotine intake markedly due to accelerated nicotine (and cotinine) metabolism during pregnancy.
Authors: Sarah H Heil; Stephen T Higgins; Ira M Bernstein; Laura J Solomon; Randall E Rogers; Colleen S Thomas; Gary J Badger; Mary Ellen Lynch Journal: Addiction Date: 2008-06 Impact factor: 6.526
Authors: Neal L Benowitz; Katherine M Dains; Delia Dempsey; Brenda Herrera; Lisa Yu; Peyton Jacob Journal: Nicotine Tob Res Date: 2009-06-12 Impact factor: 4.244
Authors: Deirdre J Murphy; Clare Dunney; Aoife Mullally; Nita Adnan; Richard Deane Journal: Int J Environ Res Public Health Date: 2013-08-27 Impact factor: 3.390
Authors: Laura R Stroud; Chrystal Vergara-Lopez; Meaghan McCallum; Allison E Gaffey; Alana Corey; Raymond Niaura Journal: Nicotine Tob Res Date: 2020-10-08 Impact factor: 4.244
Authors: Laura R Stroud; George D Papandonatos; Nancy C Jao; Raymond Niaura; Stephen Buka; Neal L Benowitz Journal: Drug Alcohol Depend Date: 2022-02-17 Impact factor: 4.492
Authors: Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton Journal: Prev Med Date: 2019-05-02 Impact factor: 4.018
Authors: Christopher A Arger; Taraneh Taghavi; Sarah H Heil; Joan Skelly; Rachel F Tyndale; Stephen T Higgins Journal: Nicotine Tob Res Date: 2019-11-19 Impact factor: 4.244
Authors: Sulamunn R M Coleman; Janice Y Bunn; Tyler D Nighbor; Allison N Kurti; Hypatia A Bolívar; Rachel F Tyndale; Stephen T Higgins Journal: Prev Med Date: 2021-04-27 Impact factor: 4.018
Authors: Jenny E Ozga; Colleen Bays; Ilana Haliwa; Nicholas J Felicione; Stuart G Ferguson; Geri Dino; Melissa D Blank Journal: Exp Clin Psychopharmacol Date: 2021-02-25 Impact factor: 3.492